title: [Systemic candidiasis in patients after kidney and heart transplantation].
abstract: Nosocomial and other severe infections are able to cause life-threatening complications in organ transplant recipients. Unter such conditions the treatment will be successful only in early status of infection. Fluconazol (Diflucan) has been used in the treatment of candidosis in cardiac and renal transplant patients with good results, and lack of adverse effects.
authors.affiliation: Dermatologische Klinik und Poliklinik, Medizinischen Fakultät (Charité), Humboldt-Universität Berlin.
authors.forename: I
authors.initials: I
authors.lastname: Tausch
authors.forename: J
authors.initials: J
authors.lastname: Pertschy
authors.forename: P
authors.initials: P
authors.lastname: Reinke
authors.forename: H
authors.initials: H
authors.lastname: Ziegler-Böhme
mesh_terms: D000328:Adult; D002177:Candidiasis / Q000188:drug therapy / Q000209:etiology*; D003428:Cross Infection / Q000188:drug therapy / Q000209:etiology*; D015725:Fluconazole / Q000627:therapeutic use*; D016027:Heart Transplantation; D006801:Humans; D016030:Kidney Transplantation; D008297:Male
chemical_list: D015725:Fluconazole
vernacular_title: Systemische Candidose bei Patienten nach Nieren- und Herztransplantation.